|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0162791,
umls-concept:C0199176,
umls-concept:C0205210,
umls-concept:C0239307,
umls-concept:C0392756,
umls-concept:C0441471,
umls-concept:C0441472,
umls-concept:C0454664,
umls-concept:C0679699,
umls-concept:C1257890,
umls-concept:C1522318,
umls-concept:C1707455,
umls-concept:C1948041
|
|
pubmed:issue |
9261
|
|
pubmed:dateCreated |
2001-4-9
|
|
pubmed:abstractText |
Patients with coronary heart disease (CHD) are the top priority for preventive cardiology. The first EUROASPIRE survey among patients with established CHD in nine countries in 1995-96 showed substantial potential for risk reduction. A second survey (EUROASPIRE II) was done in 1999-2000 in the same countries to see whether preventive cardiology had improved since the first. We compared the proportion of patients in both studies who achieved the lifestyle, risk-factor, and therapeutic goals recommended by the Joint European Societies report on coronary prevention.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0140-6736
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
31
|
|
pubmed:volume |
357
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
995-1001
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:11293642-Adrenergic beta-Antagonists,
pubmed-meshheading:11293642-Angiotensin-Converting Enzyme Inhibitors,
pubmed-meshheading:11293642-Anticoagulants,
pubmed-meshheading:11293642-Antihypertensive Agents,
pubmed-meshheading:11293642-Cholesterol,
pubmed-meshheading:11293642-Coronary Disease,
pubmed-meshheading:11293642-Diabetes Mellitus,
pubmed-meshheading:11293642-Europe,
pubmed-meshheading:11293642-Female,
pubmed-meshheading:11293642-Health Surveys,
pubmed-meshheading:11293642-Humans,
pubmed-meshheading:11293642-Hypertension,
pubmed-meshheading:11293642-Hypolipidemic Agents,
pubmed-meshheading:11293642-Life Style,
pubmed-meshheading:11293642-Male,
pubmed-meshheading:11293642-Middle Aged,
pubmed-meshheading:11293642-Obesity,
pubmed-meshheading:11293642-Patient Compliance,
pubmed-meshheading:11293642-Platelet Aggregation Inhibitors,
pubmed-meshheading:11293642-Prevalence,
pubmed-meshheading:11293642-Quality of Life,
pubmed-meshheading:11293642-Risk Factors,
pubmed-meshheading:11293642-Smoking
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. EUROASPIRE I and II Group. European Action on Secondary Prevention by Intervention to Reduce Events.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
